Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| plasma cell | 6 studies | 24% ± 5% | |
| macrophage | 4 studies | 36% ± 17% | |
| fibroblast | 4 studies | 22% ± 3% | |
| epithelial cell | 3 studies | 29% ± 7% | |
| GABAergic neuron | 3 studies | 24% ± 2% | |
| glutamatergic neuron | 3 studies | 26% ± 3% | |
| oligodendrocyte precursor cell | 3 studies | 22% ± 6% | |
| goblet cell | 3 studies | 32% ± 19% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 22% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1261.98 | 1445 / 1445 | 100% | 21.29 | 183 / 183 |
| lung | 100% | 2485.00 | 578 / 578 | 100% | 27.39 | 1155 / 1155 |
| ovary | 100% | 2349.72 | 180 / 180 | 100% | 23.12 | 430 / 430 |
| stomach | 100% | 1437.39 | 359 / 359 | 100% | 19.76 | 286 / 286 |
| breast | 100% | 2099.07 | 459 / 459 | 100% | 23.93 | 1117 / 1118 |
| intestine | 100% | 1514.25 | 966 / 966 | 100% | 20.21 | 526 / 527 |
| uterus | 100% | 2478.62 | 170 / 170 | 100% | 24.59 | 458 / 459 |
| bladder | 100% | 1703.81 | 21 / 21 | 100% | 21.09 | 502 / 504 |
| prostate | 100% | 1820.89 | 245 / 245 | 100% | 20.02 | 500 / 502 |
| pancreas | 100% | 2640.48 | 328 / 328 | 99% | 20.60 | 177 / 178 |
| thymus | 100% | 2429.65 | 653 / 653 | 99% | 20.91 | 600 / 605 |
| skin | 100% | 2299.37 | 1809 / 1809 | 98% | 20.20 | 462 / 472 |
| kidney | 100% | 1152.63 | 89 / 89 | 97% | 13.81 | 870 / 901 |
| adrenal gland | 100% | 1831.20 | 258 / 258 | 94% | 9.74 | 217 / 230 |
| liver | 100% | 1348.32 | 226 / 226 | 93% | 10.55 | 379 / 406 |
| brain | 88% | 564.83 | 2314 / 2642 | 98% | 11.40 | 690 / 705 |
| adipose | 100% | 2162.60 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 12.75 | 29 / 29 |
| spleen | 100% | 1954.51 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 23.36 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.16 | 1 / 1 |
| blood vessel | 100% | 1664.91 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 1258.95 | 850 / 861 | 0% | 0 | 0 / 0 |
| muscle | 95% | 673.43 | 763 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 89% | 1098.39 | 830 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 83% | 7.39 | 66 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006914 | Biological process | autophagy |
| GO_1901097 | Biological process | negative regulation of autophagosome maturation |
| GO_1902902 | Biological process | negative regulation of autophagosome assembly |
| GO_0045070 | Biological process | positive regulation of viral genome replication |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | TMEM39A |
| Protein name | Transmembrane protein 39A |
| Synonyms | SUSR2 |
| Description | FUNCTION: Regulates autophagy by controlling the spatial distribution and levels of the intracellular phosphatidylinositol 4-phosphate (PtdIns(4)P) pools . Modulates (PtdIns(4)P) levels by regulating the ER-to-Golgi trafficking of the phosphatidylinositide phosphatase SACM1L . .; FUNCTION: (Microbial infection) Positively regulates the replication of encephalomyocarditis virus (EMCV) via autophagy-dependent pathway. . |
| Accessions | ENST00000490099.5 C9K0C7 ENST00000319172.10 [Q9NV64-1] C9JUZ6 Q9NV64 ENST00000491685.5 ENST00000468676.5 ENST00000497993.5 ENST00000461654.1 C9IYN1 H7C5P7 ENST00000473684.5 C9JYN8 ENST00000438581.6 [Q9NV64-2] F8WAU1 |
